The Role of Rituximab in Primary Central Nervous System Lymphoma
Open Access
- 29 June 2020
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 22 (8) , 1-6
Abstract
Purpose of Review: The treatment of primary central nervous system lymphoma (PCNSL) is still under debate. One of the issues is the role of rituximab in improving the outcome. Here, we summarize the existing evidence, and comment on the literature on this topic. Recent Findings: Two randomized controlled studies have been published recently, with conflicting results. Although the evidence of the benefit of rituximab is limited, it is already incorporated into many treatment regimens, both in studies and in standard clinical practice. Summary: The use of rituximab in PCNSL is still a matter of debate. A positive effect on the outcome is uncertain. However, there are no clinical signs of significantly increased toxicity. The uncertain positive effect should therefore be weighed against the increased costs of the treatment.Keywords
Funding Information
- University Medical Center Rotterdam
This publication has 40 references indexed in Scilit:
- Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)Journal of Clinical Oncology, 2013
- Rituximab significantly improves complete response rate in patients with primary CNS lymphomaJournal of Neuro-Oncology, 2012
- Age, gender, and racial differences in incidence and survival in primary CNS lymphomaBritish Journal of Cancer, 2011
- Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderlyAnnals of Oncology, 2011
- High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphomaNeuro-Oncology, 2010
- Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS LymphomaJournal of Clinical Oncology, 2007
- Temozolomide and methotrexate for primary central nervous system lymphoma in the elderlyJournal of Neuro-Oncology, 2007
- Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'AdulteJournal of Clinical Oncology, 2005
- High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962Journal of Clinical Oncology, 2003
- Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartmentBlood, 2003